The Cooper Companies, Inc. (NASDAQ:COO) Shares Bought by HB Wealth Management LLC

HB Wealth Management LLC grew its stake in shares of The Cooper Companies, Inc. (NASDAQ:COO) by 24.1% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 2,913 shares of the medical device company’s stock after acquiring an additional 565 shares during the period. HB Wealth Management LLC’s holdings in Cooper Companies were worth $268,000 at the end of the most recent reporting period.

Several other institutional investors have also modified their holdings of the company. Ashton Thomas Securities LLC purchased a new stake in Cooper Companies during the third quarter worth $25,000. Covestor Ltd raised its stake in shares of Cooper Companies by 144.9% during the 3rd quarter. Covestor Ltd now owns 338 shares of the medical device company’s stock worth $37,000 after buying an additional 200 shares during the last quarter. Brown Brothers Harriman & Co. boosted its position in shares of Cooper Companies by 191.0% in the 3rd quarter. Brown Brothers Harriman & Co. now owns 419 shares of the medical device company’s stock worth $46,000 after buying an additional 275 shares in the last quarter. West Financial Advisors LLC acquired a new stake in Cooper Companies in the 4th quarter valued at about $49,000. Finally, Friedenthal Financial purchased a new position in Cooper Companies during the 3rd quarter valued at about $50,000. Hedge funds and other institutional investors own 24.39% of the company’s stock.

Wall Street Analysts Forecast Growth

Several research firms have recently commented on COO. Morgan Stanley lowered their price target on shares of Cooper Companies from $104.00 to $102.00 and set an “equal weight” rating on the stock in a research report on Friday, December 6th. StockNews.com downgraded Cooper Companies from a “buy” rating to a “hold” rating in a research report on Wednesday, December 11th. Wells Fargo & Company upped their price objective on Cooper Companies from $115.00 to $118.00 and gave the company an “overweight” rating in a research report on Friday, December 6th. Needham & Company LLC reiterated a “hold” rating on shares of Cooper Companies in a research report on Friday, December 6th. Finally, Citigroup reduced their target price on shares of Cooper Companies from $116.00 to $115.00 and set a “buy” rating on the stock in a report on Friday, December 6th. Four analysts have rated the stock with a hold rating and nine have assigned a buy rating to the stock. According to data from MarketBeat.com, Cooper Companies presently has a consensus rating of “Moderate Buy” and an average price target of $117.00.

Cooper Companies Stock Performance

Shares of COO stock opened at $97.70 on Friday. The company has a debt-to-equity ratio of 0.32, a quick ratio of 1.12 and a current ratio of 1.91. The firm has a market capitalization of $19.50 billion, a price-to-earnings ratio of 50.10, a price-to-earnings-growth ratio of 2.41 and a beta of 0.99. The Cooper Companies, Inc. has a one year low of $84.76 and a one year high of $112.38. The company has a 50 day moving average price of $95.95 and a 200 day moving average price of $99.23.

Cooper Companies (NASDAQ:COO) last issued its earnings results on Thursday, December 5th. The medical device company reported $1.04 earnings per share for the quarter, topping the consensus estimate of $1.00 by $0.04. Cooper Companies had a return on equity of 9.38% and a net margin of 10.07%. The business had revenue of $1.02 billion for the quarter, compared to analyst estimates of $1.03 billion. During the same period last year, the company posted $0.87 EPS. The business’s quarterly revenue was up 9.8% on a year-over-year basis. Sell-side analysts anticipate that The Cooper Companies, Inc. will post 3.98 EPS for the current year.

Cooper Companies Profile

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.